Treatment Options for Resistant Lymphoma

Course Authors

F. Waheed, M.D., R. Lerner, M.D., T. Ahmed, M.D., and K. Rashid, M.D.

Drs. Waheed and Rashid are Fellows in the Hematology & Oncology training program of the Department of Medicine of New York Medical College at Westchester Medical Center. Dr. Ahmed is Professor of Medicine and Chief of Oncology at New York Medical College and Director of the Zalmen A. Arlin Cancer Institute, Valhalla, NY. Drs. Waheed, Ahmed and Rashid report no comercial conflicts of interest.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Upon completion of this Cyberounds^®, you should be able to:

• Discuss the role of high-dose chemotherapy in lymphoma

• Discuss the treatment options for patients with resistant lymphomas including tandem transplant

• Discuss the side effects of various chemotherapeutic agents used as conditioning chemotherapy and other complications associated with stem cell transplant.